1. Home
  2. Archives
  3. Vol 8 (2026) Issue 1
  4. Articles

Nanoemulsions of Biosurfactant and Cinnamon Essential Oil: A Promising Antimicrobial Approach for Oral Pathogens

Abstract

Dental and oral care products often contain Sodium Lauryl Sulfate (SLS), which can cause allergic reactions and mucosal infection. Biosurfactants (BS) and cinnamon essential oil (CEO) are safer alternatives due to their antimicrobial properties. This study screens BS form five bacterial isolates, CEO, and their nanoemulsions prepared by low-energy method (NEL) and high- energy method (NEH) for inhibiting oral pathogens. Results showed that BS from Bacillus altitudinis were most effective against Candida albicans, while BS from Bacillus siamensis were most effective against Streptococcus mutans and Enterococcus faecalis. The minimum concentrations of CEO inhibiting C. albicans were 1900 ppm and both S. mutans and E. faecalis were 490 ppm. The minimum NEL and NEH concentration inhibiting C. albicans was 3.125 ppm BS+ 175 ppm CEO and 6.25 ppm BS + 350 ppm CEO, respectively. The minimum NEL concentration inhibiting S. mutans and E. faecalis was 7.82 ppm BS + 120 ppm CEO and 1.95 ppm BS + 120 ppm CEO, while the minimum concentration of both NEH was 3.125 ppm BS+ 175 ppm CEO. These findings suggest that BS combined with CEO in nanoemulsions are effective in inhibiting oral pathogens and can serve as promising alternatives to SLS.

Keywords

1. Introduction

According to the World Health Organization (WHO) in 2023, there are 3.5 billion people affected by oral diseases globally, including 2 billion cases of dental caries. Dental caries, also known as tooth decay or cavities, is a common chronic infectious disease that result in tooth damage [1]. It is caused by various microorganisms, including Streptococcus mutans, Candida albicans, and Enterococcus faecalis [2]. S. mutans is an etiological agent of dental caries affecting tooth enamel. E. faecalis is commonly found in root canal systems, contributing to chronic apical periodontitis. C. albicans can adhere to tooth surfaces and produce acid which demineralizes teeth. This condition is associated with S. mutans and E. faecalis in biofilm formation [3-5].

One way to inhibit growth and biofilm formation on tooth surfaces is by using commercial products such as toothpaste and mouthwash products containing surfactant as one of their active components. Adding surfactants to the formulation can act as foaming, antibacterial, and antibiofilm agents, also emulsifiers. Therefore, the type and concentration of surfactants during toothpaste and mouthwash products formulation are essential. Insufficient surfactant concentration can reduce product effectiveness, while excessive surfactant concentration can cause irritation, discomfort, and oral toxicity [6-7]. Sodium lauryl sulfate (SLS), an anionic surfactant used at 0.5%-2% concentrations can exhibit antibacterial activity by increasing cell membrane permeability and causing cell lysis [6]. However, SLS is also known for its toxic effects, including burning oral sensations, oral toxicity, irritation reactions, and mucosal inflammation [7].

According to Elshikh et al. [8], microbial biosurfactants possess antimicrobial properties, stable emulsification capacity, the ability to enhance the bioavailability of compounds, low toxicity, and an environmentally friendly nature, making them suitable for use in oral health products. These attributes highlight their potential as alternatives to SLS. Another alternative to replace the use of SLS as an antimicrobial agent is cinnamon essential oil (Cinnamomum burmannii). C. burmannii essential oil consists of cinnamaldehyde (68.3%-82%), cinnamyl acetate (2.5%- 16%), cinnamyl alcohol (2.25%-4.6%), and cinnamic acid

cid (3%-8%) [9]. Cinnamaldehyde exhibits antibacterial and antibiofilm activities against various bacteria. For S. mutans, the Minimum Inhibitory Concentration (MIC) value of cinnamaldehyde is 1000 µg/mL, and the Minimum Bactericidal Concentration (MBC) is 2000 µg/mL. Concentrations ranging from 125 to 500 µg/mL of this compound are effective in reducing biomass and metabolic activity of S. mutans biofilm after 24 hours incubation [10]. For E. faecalis, the MIC value of cinnamaldehyde is 250 µg/mL and the MBC is 1000 µg/ mL [11]. Concentrations from 312.5 to 5000 µg/mL of this compound are effective in reducing biomass and metabolic activity of E. faecalis biofilm after 72 hoursincubation [12]. For C. albicans, the MIC value is 1000 μg/mL and the Minimum Fungicidal Concentration (MFC) value is 2000 μg/mL. It is found that the concentration of 200 to 4000 μg/mL are effective in reducing C. albicans biofilm after 24 hoursincubation [13].

Cinnamon essential oil (CEO) is notoriously difficult to dissolve in water. However, by reducing its particle size up to the nano level, its stability and solubility can be enhanced in water, thereby increasing its effectiveness as an antimicrobial agent [14]. Fattahi et al. [15] discovered that the combination of CEO and Tween 80 nanoemulsion-based exhibited better antifungal properties compared to macroemulsion against Aspergillus niger and Mucor racemosus. The sizes of the macroemulsion and nanoemulsion obtained were 242–362 nm and 59–80 nm, respectively. Da Silva et al. [16] states that Origanum vulgare essential oil combined with Tween 80 nanoemulsion-based showed better antimicrobial properties against Escherichia coli, Salmonella enteritidis, Staphylococcus aureus, and Listeria monocytogenes compared to the emulsion. The size of the nanoemulsion obtained was 54.47 nm, however, the size of the emulsion was not mentioned. Pontes et al [17] reported that geraniol nanoemulsion was more effective as an antifungal for C. albicans compared to macroemulsion. The MIC and MFC value of geraniol macroemulsion was 300 μg/mL and 600 μg/mL, respectively, whereas the MIC value of geraniol nanoemulsion was 18.75 μg/mL and MFC was 37.5 μg/mL. This study used polyoxyethylene (20) cetyl ether and soy phosphatidylcholine surfactant with 2:1 ratio and the sizes of geraniol nanoemulsion were 232.2 nm.

Microbial biosurfactants and CEO present promising alternatives due to their natural origins and antimicrobial properties. Previous studies have demonstrated the antimicrobial efficacy of these compounds individually. First, this study explores their combined effect in nanoemulsion form, which is a relatively unexplored area. Nanoemulsions can enhance the stability and solubility of hydrophobic compounds like CEO, potentially increasing their antimicrobial effectiveness. Second, this study evaluates the antimicrobial properties of microbial biosurfactants against common oral pathogens. Lastly, this study investigates the potential of nanoemulsions combining cinnamon essential oil and microbial biosurfactants to suppress oral pathogen.

2. Methodology

2.1. Materials

This study utilized five bacterial isolates obtained from the Jatibarang oil well in West Java, designated as DS4, DS14, DS16, DS30, and DS33, as biosurfactant-producing isolates. The oral pathogens used in this study were Streptococcus mutans ATCC 25175, Enterococcusfaecalis ATCC 29212, and Candida albicans ATCC 10231. The following medium were used: Nutrient Agar (NA) Oxoid medium, Nutrient Broth (NB) Oxoid medium, Potato Dextrose Broth (PDB) Oxoid medium, Potato Dextrose Agar (PDA) Oxoid medium, Tryptic Soy Broth (TSB) Himedia medium, Brain Heart Infusion Broth (BHI) Oxoid medium, cinnamon essential oil (CEO) (100% v/v), and production medium SMSSe (Stone mineral salt solution) consisting of 0.5 grams CaCO3; 2.5 grams NH4NO3; 1 gram Na2HPO4,7H2O; 0.5 grams KH2PO4; 0.5 grams MgSO4.7H2O; 0.2 grams MnCl2.7H2O supplemented with 2.12% (w/v) molasses, 0.01% (w/v) KH2PO4, and 0.41% (w/v) urea [18].

2.2. Characterization and Identification of Biosurfactant-Producing Bacteria

Characterization of the bacteria was performed by observing their morphology, including size, shape, edge, elevation, color, and optical properties [19]. Microscopic characterization was carried out using Gram staining [19] and observed under a light microscope at 1000x magnification with immersion oil. Bacterial identification was conducted using the 16S rRNA gene marker with forward primer 785F 5' GGATTAGATACCCTGGTA '3 and reverse primer 907R 5' CCGTCAATTCMTTTRAGTTT '3. The sequencing result in contig sequence was compared with the GeneBank database (NCBI) using Blastn algorithm. Phylogenetic tree was constructed using MEGA XI software with Neighbor-Joining method and 1000x bootstrap.

2.3. Production and Extraction Microbial Biosurfactant

The biosurfactant-producing bacterial cultures were initially activated in NB medium for 24 hours at room temperature, followed by a second activation in NB medium for 12 hours. After the second activation, the cultures were transferred to production medium and incubated for 72 hours on a shaker at 150 rpm and 50°C. Biosurfactant extraction was performed using an acid extraction method with chloroform:methanol (2:1), followed by evaporation and purification using deionized water [20].

2.4. Minimum Inhibitory Concentration (MIC)

Screening of microbial biosurfactants, CEO, and nanoemulsion was conducted using a serial dilution method against three oral pathogens (S. mutans, E. faecalis, and C. albicans) [21]. The concentration of biosurfactant tested against C. albicans was 5000 ppm, 2500 ppm, 1.250 ppm, 625 ppm, 312.5 ppm, 156.25 ppm and 78.125 ppm, while for S. mutans and E. faecalis, the concentrations was 1000 ppm, 500 ppm, 250 ppm, 125 ppm, 62.5 ppm, 31.25 ppm, and 15.62 ppm. The concentrations of CEO used against all three oral pathogens were 15.600 ppm, 7800 ppm, 3900 ppm, 1950 ppm, 975 ppm, 487.5 ppm, 243.75 ppm, 121.87 ppm, 60.93 ppm, 30.46 ppm, 15.23 ppm, and 7.61 ppm. The concentrations nanoemulsion used against all three oral pathogens were 100 ppm BS + 5600 ppm CEO and diluted to a concentration 50 ppm BS + 2800 ppm CEO; 25 ppm BS + 1400 ppm CEO; 12.5 ppm BS + 700 ppm CEO; 6.25 ppm BS + 350 ppm CEO; 3.125 ppm BS + 175 ppm CEO; 1.562 ppm BS + 87.5 ppm CEO; and 0.781 ppm biosurfactant + 43.74 ppm CEO. The microbial test cultures were adjusted to 105 CFU/mL for both bacteria and yeast, incubated at 37°C under anaerobic conditions, and observed after 12-hour. MIC results for biosurfactants were measured by absorbance at 600 nm wavelength and the growth inhibition percentages at different biosurfactant concentrations for each pathogenic strain were calculated as:

% Growth Inhibition = \[[1 - (AC/AO)] \times 100\] (1)

AC represents the well absorbance with biosurfactant and AO is the absorbance of the control well (without biosurfactant) [20]. MIC result for CEO and nanoemulsion after incubation were measured by treating the remaining samples in the well with 0.3% resazurin (30 \(\mu\)L) and reincubating them for 2-4 hours before checking for color changes. In the resazurin test, the observed color change was from blue to pink [21].

2.5. Fractional Inhibitory Concentration (FIC)

This test was conducted to determine the interaction properties of biosurfactants and CEO, assessing their combined

effects to be classified as synergistic, antagonistic, additive, or indifferent. The Fractional Inhibitory Concentration Index (FICI) was calculated using the equation [22]:

\[FICI = (MICAB/MICA) + (MICBA/MICB)\] (2)

MICAB is the minimum inhibitory concentration (MIC) of BS tested in combination with CEO, MICA is the MIC of BS only, MICBA is the MIC of CEO tested in combination with BS and MICB is the MIC of CEO only. Synergy was defined as FICI \(\leq\)0.5, while indifference was defined as FICI between >0.5 and 4 and antagonism as FICI > 4 [22].

2.6. Production and Characterization Nanoemulsion

Nanoemulsion was prepared using biosurfactant at 2000 ppm (NE1), 1000 ppm (NE2), 500 ppm (NE3), and 100 ppm (NE4) concentrations, which then combined with 47,600 ppm cinnamon essential oil. This formula was then processed into nanoemulsion using low-energy nanoemulsion (NEL) by vortexing for 5 minutes, and high-energy nanoemulsion (NEH) by vortexing for 5 minutes followed by sonication using an ultrasonicator (Omniruptor Sonicator) at 50 Hz intensity for 20 minutes [23]. The nanoemulsion formula is then selected based on visualization and the presence or absence of phase separation. The selected nanoemulsion formula was then characterized by particle size measurement using PSA and zeta potential analysis (Nano-Particle Size Analyzer Horiba SZ-100).

2.7. Statistical Analysis

The result of MIC biosurfactant are provided as the average of four experiments and error bars showed the standard errors of the deviations. A p-value of less than 0.05 is considered statistically significant.

Table 1. Characteristics of five isolates of biosurfactant-producing bacteria

Macroscopic characteristicMicroscopic characteristic
IsolateSizeShapeMarginElevationOptical propertyColorGramForm
DS 4ModerateCurledFlatCream
DS 14SmallCurledRaisedWhite
DS 16ModerateCircularEntireFlatOpaqueWhite+Bacilli
DS 30ModerateEntireFlatCream
DS 33ModerateCurledUmbonateWhite

3. Result and Discussion

The results of this study highlight the potential of microbial biosurfactants produced by various Bacillus species and cinnamon essential oil (CEO) as effective antimicrobial agents against common oral pathogens. These findings provide insights into the development of safer alternatives to synthetic chemical agents like SLS in dental and oral care products.

3.1. Characterization and Identification of Biosurfactant-Producing Bacteria

Based on the macroscopic characterization results shown in Table 1, the bacterial isolates shared similarities in shape and optical properties but differed in size, elevation, edge, and color. Microscopic observations revealed that all five isolates were Gram-positive bacilli. Identification using the 16S rRNA gene marker indicated that these bacteria belong to the genus Bacillus. Phylogenetic analysis in Figure 1 identified the isolates DS4, DS14, DS16, DS30, and DS33 as B. altitudinis, B. siamensis, B. licheniformis, B. subtilis, and B. veleznesis respectively. This diversity in speciessuggests a wide range of potential biosurfactant-producing capabilities within the genus, which could be exploited for various antimicrobial applications.

3.2. Minimum Inhibitory Concentration (MIC) of Biosurfactant and CEO

Based on the C. albicans growth inhibition percentage shown in Figure 2(a), biosurfactants produced by Bacillus altitudinis exhibited the highest inhibition at 48% with a biosurfactant concentration of 5000 ppm. The minimum concentration of biosurfactant inhibited C. albicans growth was 312.5 ppm, resulting in a 3% inhibition. For E. faecalis and S. mutans, as shown in Figures 2(b) and 2(c), the biosurfactant produced by B. siamensis exhibited the highest inhibition at 1000 ppm, with 80% inhibition for S. mutans and 50% for E. faecalis. The minimum biosurfactant concentration inhibited the growth of both bacteria was 15.62 ppm, with 15% inhibition percentage of for S. mutans and 5% for E. faecalis.

Microbial biosurfactants are surface-active compounds synthesized by microorganisms, characterized by their amphiphilic structure comprising hydrophilic (polar) and hydrophobic (nonpolar) groups [24]. This structure enables biosurfactants to interact with microbial cell membrane components, disrupting cell structure and metabolism [25]. The genus Bacillus is known for producing biosurfactants with significant antimicrobial properties. Specifically, B. altitudinis produces lipopeptide biosurfactants

9

Figure 1.Phylogenetics analysis offive isolates of biosurfactant-producing bacteria usingMEGAXIsoftwarewithNeighbourJoining method and 1000x bootstrap.

2

Figure 2.Percentage ofinhibition of oral pathogens by biosurfactantsfromB. altitudinis,B.siamensis,B.licheniformis,B. nakamurai, and B.subtilisusingtheMinimumInhibitoryConcentration(MIC)method.(a)Candida albicans,(b) Streptococcusmutans, (c)Enterococcus faecalis;(*)indicatessignificantdifferenceswithp-value<0.05;(ns)indicatesinsignificantdifferencewithp-value>0.05.

2

Figure 3.(a)CinnamonEssentialOil(CEO)MICtest onS.mutans using resazurin as colorindicator,with the highest concentration of 1500ppmanddilutedtothe lowest concentrationof8ppm,withmediumaddedwithculture as anegative control andthemediumonlyas a blanko.(b)MICtest ofNELandNEHinhibitedC. albicans using resazurin as colorindicator at concentration 100 ppmBS+5600 ppm CEOand diluted to lowest concentration of 0.78 ppmBS+43.75 ppmCEO.WithBS(Biosurfactant);CEO(Cinnamon essential oil);NEL (Nanoemulsionlowenergymethod);NEH(Nanoemulsionhighenergymethod)

with antifungal properties [26-27], as evidence by the inhibition of C. albicans growth at a concentration of 2500 μg/mL [28]. Similarly, B. siamensis produces a lipopeptide biosurfactant, that exhibits antimicrobial activity against oral pathogenssuch as S. mutans and E. faecalis[29-31]. MIC tests were also conducted on cinnamon essential oil (CEO) results were observed based on the color change using resazurin as indicator. As shown in Figure 3(a), color change from blue to pink indicates microbial growth, while no color change indicates inhibition of microbial activity. Based on MIC testing of CEO, the minimum concentrations inhibited the growth of C. albicans was 1900 ppm, while for S. mutans and E. faecalis, the concentration was 490 ppm for both.

Cinnamon essential oil (CEO), primarily composed of cinnamaldehyde, exhibits strong antibacterial and antifungal activity by disrupting cell wall and membrane integrity [32]. Previous research has shown that CEO can inhibit the growth of C. albicans at concentrations <0.03% (v/v) [33] and effectively inhibit the growth of S. mutans and Enterococcus, both are pathogens responsible for dental caries and other oral infections [34]. The hydrophobic nature of CEO, however, limits its solubility in water, reducing its effectiveness [35]. By using biosurfactants to emulsify the CEO, it can be easily solubilized in water-based systems, enhancing its biological availability [35-36]. Both organic

compounds can be mixed into nanoemulsions to increase the potency of CEO and biosurfactant as antimicrobials.

3.3. Fractional Inhibitory Concentration (FIC)

The Fractional Inhibitory Concentration (FIC) analysis indicates the interaction between biosurfactants and CEO. The calculation was derived from MIC of biosurfactants, CEO, and their combination as shown in Table 2. Based on Table 2, the FIC values for biosurfactant and CEO against C. albicans and E. faecalis were 0.1 and 0.3697 respectively, indicating a synergistic relationship since both FIC values are ≤ 0.5. Meanwhile, the FIC value for S. mutans was 1.01, indicating no interaction or an indifference between the two compounds, asthe FICvalue falls within the range of 1 – 4 [22].

The FIC analysis revealed a synergistic relationship between biosurfactants and CEO against C. albicans and E. faecalis, with FIC values of 0.1 and 0.3697, respectively. This synergy suggests that the combination of these agents could enhance their antimicrobial effectiveness, potentially allowing for lower concentrations of each to be used in formulations [37-38]. Meanwhile the FIC value for S. mutans was 1.01, indicating an indifferent relationship. This suggests that while biosurfactants and CEO are effective individually, their combination does not significantly enhance their inhibitory effects against S. mutans [39].

MicrobesMIC BSMIC
CEO
MIC BS + CEOFIC BSFIC CEOFICIIdentified [22]
C. albicans312.519003.125 BS + 175 CEO0.010.0920.1Synergistic
S. mutans15.6254907.82 BS + 250 CEO0.500480.510201.01068Indifferent
E. faecalis15.6254901.95 BS + 120 CEO0.12480.24490.3697Synergistic

Table 2. The result of Minimum Inhibitory Concentration (MIC) and Fractional Inhibitory Concentration (FIC) biosurfactant and CEO

Notes: BS (Biosurfactant); CEO (Cinnamon essential oil; NEL (Nanoemulsion low energy method); NEH (Nanoemulsion high energy method)

3.4. Production and Characterization of Nanoemulsion

The nanoemulsion results showed a distinctive difference in color formation between NEH and NEL. NEL at concentrations NE1 to NE4 displayed a yellow color change and rapid phase separation, while NEH changed to a milky white color. NEH at concentrations NE1-NE3 showed residual CEO that was not well emulsified, leaving oil on the walls and in the bottom of the falcon tube. In contrast, NEH concentration NE4 showed good emulsification with minimal residual oil compared to the other nanoemulsion concentrations (Figure 4).

The final biosurfactant concentration selected was 100 ppm (NE4), which was then formulated with 5600 ppm CEO. The concentration of CEO is selected based on the range concentration of MIC value inhibited the growth of the three oral pathogens and is the best concentration which completely emulsified with no residual oil. Table 3 shows the NEH particle size measurement was 218.2 nm, smaller than the NEL size of 405.02 nm. The zeta potential test results for both were \(\geq\) -30 mV, indicating sufficient stability for both formulas. However, NEL had a polydispersity index (PI) \(\geq\) 0.5, indicating a non-homogeneous particle dispersion, while NEH had a PI \(\leq\) 0.5, indicating a homogeneous particle dispersion.

Antimicrobial nanoemulsions are emulsified mixtures of detergent, oil, and water with particle sizes ranging from 100 to 800 nm. These mixtures have demonstrated broad antimicrobial activity against bacteria, enveloped viruses, and fungi at concentrations that are nontoxic to animals [40]. Despite the wide range of sizes, smaller droplets are generally more effective against microorganisms due to their higher surface area-to-volume ratio, which enhances their antimicrobial activity [41]. Smaller droplets are also more stable and less prone to coalescence, ensuring consistent antimicrobial activity over time [42]. Therefore, the preparation method is crucial to achieve the smallest possible nanoemulsion droplet size.

10

Figure 4. (a) Visualization of nanoemulsion low energy (NEL) after vortex for 5 minutes, (b) Visualization of nanoemulsion high energy (NEH) after vortex 5 minutes followed by sonication for 20 minutes. With NEL (Nanoemulsion low energy method); NEH (Nanoemulsion high energy method). NE1 (2000 ppm BS + 47.600 ppm CEO); NE2 (1000 ppm BS + 47.600 CEO); NE3 (500 ppm BS + 47.600 CEO); NE4 (100 ppm BS + 47.600 CEO); BS (Biosurfactant); CEO (Cinnamon Essential Oil)

Table 3.Result of particle size analyzer and zeta potential of nanoemulsion
FormulationTreatmentPSA (nm)Zeta Potential
(mV)
PI
NEL405.02 ± 25.73-37.02 ± 0.470.698 ± 0.007
100 ppm BS + 5600 ppm CEONEH218.2 ± 5.73-40.76 ± 1.700.216 ± 0.003

Notes:BS(Biosurfactant); CEO(Cinnamon essential oil; NEL(Nanoemulsion lowenergy method);NEH(Nanoemulsion high energy method)

The nanoemulsion method is differentiated based on the energy used during its formation, which can be either high energy or low energy. The high-energy method involves the input of significant energy such as ultrasonication and high-shear stirring to create nanosized droplets.In contrast, the low-energy method relies on internal chemical or temperature changes to form nanoparticles without the need of external pressure [43].

This study employs both low-energy and highenergy methods for the formation of emulsions. In spontaneous emulsification, the organic phase, consisting of oil, surfactant, and cosurfactant, is simply added to the aqueous phase with gentle stirring. The surfactant in the organic phase has a high affinity for the continuous phase. Therefore, when two phases (the organic or dispersed phase and the aqueous or continuous phase) are mixed, turbulence forms, and the surfactant quickly diffuses into the aqueous phase, forming a layer or film around the dispersed oil droplets. This reduces the interfacial tension, resulting in the spontaneous formation of an emulsion system [44]. The emulsification formed between biosurfactants and CEO is classified as spontaneous emulsification with a particle size of 405.02±25.73 nm. However, this emulsion is short-lived due to rapid phase separation. This instability occurs due to several factors such as rapid stirring using a vortex, which can cause turbulence leading to nonhomogeneous dispersion of globules and resulting in larger particle size [45]. On the other hand, too slow stirring can prevent the nanoemulsion from becoming homogenous [45]. In addition, inappropriate biosurfactant concentration can also lead to phase separation and it is related to hydrophilic- lipophilic balance (HLB) value, which indicates the strength and proportion of the hydrophilic and lipophilic portions of the biosurfactant molecules [46]. HLB plays a crucial role because it stabilizes nanoemulsions by enhancing the affinity between interacting molecules and reducing the interfacial tension between water and oil phase [47]. A higher HLB values can enhance result in smaller and more homogenous particle size because it can

assist in reducing particle aggregation and producing more uniform particles [47].

The nanoemulsion method using high-energy techniques includes ultrasonication, which enhances acoustic cavitation. This process leads to the formation and collapse of microbubbles due to pressure fluctuations from a sound wave. These localized shock waves ultimately produce micro-explosions that cause larger droplets to break down into sub-micron sizes [48]. The particle size of nanoemulsion produced in this study using ultrasonication is 218.2 ± 5.73 nm. It is larger compared to the nanoemulsion size obtained using the surfactants Tween 80 and Span 80, which has the particle size of 90 ± 2.49 nm with cinnamon essential oil is [49]. The use of nanoemulsions as antimicrobial agents is an emerging innovation in the healthcare field.

3.5. Minimum Inhibitory Concentration (MIC) Nanoemulsion

Figure 4(b) shows the comparison of MIC test results between NEL and NEH in inhibiting the growth of C. albicans. The concentration used was 100 ppm biosurfactant + 5600 ppm CEO, diluted down to the lowest concentration of 0.781 ppm biosurfactant + 43.75 ppm CEO. Based on the changes of color, the minimum NEL concentration inhibited the growth of C. albicans was 3.125 ppm biosurfactant + 175 ppm CEO, lower than the NEH, which required 6.25 ppm BS + 350 ppm CEO. For S. mutans and E. faecalis, the minimum NEL concentrationsinhibited their growth were 7.82 ppm BS + 120 ppm CEO and 1.95 ppm BS + 120 ppm CEO, respectively. For S. mutans and E. faecalis the minimum concentration of NEH inhibited their growth was 3.125 ppm BS + 175 ppm CEO.

Nanoemulsions do not cause the development of resistant strains because of their mechanism, which involves a non- specific disruption of bacterial cell membranes. Additionally, nanoemulsions exhibit long-term storage stability, they can maintain their effectiveness for up to two years [50]. For instance, a nanoemulsion with Triton-X100, having an average particle diameter of 308 nm, has shown remarkable inhibitory

effects against the growth of cariogenic S. mutans even at an extremely high dilution. This nanoemulsion effectively preventsthe adhesion of S. mutans to glass surfaces and inhibits biofilm formation [50]. A biosurfactant-based nanoemulsion with a size of 218.2 ± 5.73 nm can inhibit the growth of S. mutans and E. faecalis at a minimum concentration of 3.12 ppm BS + 175 ppm MA. Ciprofloxacin HCl (CPX NE) nanoemulsion can inhibit the biofilm formation of E. faecalis, enhancing the effectiveness of CPX immersion against Enterococcus. A water-in-oil (w/o) type of nanoemulsion was prepared using the high-shear ultrasonication method involving oleic acid, Span 80, and Transcutol P. Thermodynamic and rheological parameters indicated the formation of the w/o nanoemulsion. In vitro applications were conducted in phosphate buffer solution and artificial saliva. Fluorescence mapping showed that the nanoemulsion could inhibit or remove E. faecalis biofilm both before and after treatment [51]. Lin et al.[52] reported that cinnamon essential oil-based nanoemulsion supplemented with Tween-80 inhibited the growth of C. albicans at a concentration of 1 mg/mL. Meanwhile, research by Juniatik et al.[53] indicated that nanoemulsion mouthwash formulations containing lemongrass and keffir lime oils, supplemented with Tween-80 and PEG, were more effective in inhibiting C. albicans growth compared to single or combined oils without nanoemulsion.

4. Conclusion

The study demonstrates that microbial biosurfactants combined with CEO in nanoemulsions are effective in inhibiting the growth of common oral pathogens. The low toxicity and natural origin of these compounds present them as promising alternatives to SLS in dental and oral care products. The use of these nanoemulsions offers a novel approach to enhance the solubility and bioavailability of hydrophobic antimicrobial agents like CEO. Further research could explore on formulations optimization for commercial applications and evaluating their long-term efficacy and safety in clinical settings.

Acknowledgements

The authors would like to express their sincere gratitude to Lembaga Pengelola Dana Pendidikan (LPDP) for financial support.

Research Intelligence

Data from OpenAlex ↗

Metrics

0.00
FWCIfield-weighted
15th
Percentilevs same year + field
Article
Work type
Open Access

Semantic Profile AI-classified research signals

Institution Network

  • Bandung Institute of Technology ID
    Isty Adhitya Purwasena · Anriansyah Renggaman · Dzulianur Mutsla · Nurul Wahyuni · Annisa Afiva · Dea Ajeng Pratiwi

References

  1. ] Barani-Sveçla M, Buleshkaj S. Etiopathogenesis of Dental Caries. IntechOpen; 2024. doi: 10.5772/ intechopen.114225
  2. ] Kouidhi B, Fdhila K, Slama RB, Mahdouani K, Hentati H, Najjari F, Bakhrouf A, Chaieb K. Molecular detection of bacteria associated to dental caries in 4–12-year-old Tunisian children. Microbial Pathogenesis. 2014;71:32- 36.
  3. ] Lemos JA, Palmer SR, Zeng L, Wen ZT, Kajfasz JK, Freires IA, Abranches J, Brady LJ. The Biology of Streptococcus mutans. Microbiology Spectrum. 2019;7(1):1-18. doi: 10.1128/microbiolspec.gpp3-0051- DOI: 10.1128/microbiolspec.gpp3-0051-
  4. ] Khalifa L, Shlezinger M, Beyth S, Houri-Haddad Y, Coppenhagen-Glazer S, Beyth N, Hazan R. Phage therapy against Enterococcus faecalis in dental root canals. J Oral Microbiol. 2016;8(1):32157. doi: 10.3402/ jom.v8.32157
  5. ] Core J. Candida spp. and its role in dental caries. J Dent Res. 2016;95(10):1345-1353. doi: 10.1177/0022034516659515 DOI: 10.1177/0022034516659515
  6. ] Aspinall SR, Parker JK, Khutoryanskiy VV. Oral care product formulations, properties and challenges. Colloids Surf B Biointerfaces. 2021;200:111567. doi: 10.1016/j. colsurfb.2021.111567 DOI: 10.1016/j
  7. ] Kasi SR, Özcan M, Feilzer AJ. Side effects of sodium lauryl sulfate applied in toothpastes: A scoping review. Am J Dent. 2022;35(2):84-88.
  8. ] Elshikh M, Marchant R, Banat IM. Biosurfactants: promising bioactive molecules for oral-related health applications. FEMS Microbiol Lett. 2016;363(18):fnw213. doi: 10.1093/femsle/fnw213 DOI: 10.1093/femsle/fnw213
  9. ] Fajar A, Ammar GA, Hamzah M, Manurung R, Abduh MY. Effect of tree age on the yield, productivity, and chemical composition of essential oil from Cinnamomum burmannii. Curr Res Biosci Biotechnol. 2019;1(1):17-
  10. doi: 10.5614/crbb.2019.1.1/SCDI5665 DOI: 10.5614/crbb.2019.1.1/scdi5665
  11. ] He Z, Huang Z, Jiang W, Zhou W. Antimicrobial Activity of Cinnamaldehyde on Streptococcus mutans Biofilms. Front Microbiol. 2019;10:2441. doi: 10.3389/ fmicb.2019.02241
  12. ] Ferro TAF, Araújo JMM, dos Santos Pinto BL, dos Santos JS, Souza EB, da Silva BLR, Colares VLP, Novais TMG, Filho CMB, Struve C, Calixto JB, Monteiro-Neto V, da Silva LCN, Fernandes ES. Cinnamaldehyde Inhibits Staphylococcus aureus Virulence Factors and Protects against Infection in a Galleria mellonella Model. Front Microbiol. 2016;7:2052. doi: 10.3389/fmicb.2016.02052 DOI: 10.3389/fmicb.2016.02052
  13. ] Akshaya BS, Premraj K, Iswarya C, Muthusamy S, Ibrahim HM, Khalil HE, Ashokkumar V, Vickram SV, Senthil KV, Palanisamy S, Thirugnanasambantham KC. Cinnamaldehyde inhibits Enterococcus faecalis biofilm formation and promotes clearance of its colonization by modulation of phagocytes in vitro. Microb Pathog. 2023;181:106157. doi: /10.1016/j.micpath.2023.106157 DOI: 10.1016/j.micpath.2023.106157
  14. ] Wijesinghe GK, de Oliveira TR, Maia FC, de Feiria SB, Barbosa JP, Joia F, Boni GC, Höfling JF. Efficacy of true cinnamon (Cinnamomum verum) leaf essential oil as a therapeutic alternative for Candida biofilm infections. Iran J Basic Med Sci. 2021;24(6):787-795. doi: 10.22038/ ijbms.2021.53981.12138
  15. ] Liu X, Chen L, Kang Y, He D, Yang B, Wu K. Cinnamon essential oil nanoemulsions by high- pressure homogenization: Formulation, stability, and antimicrobial activity. LWT. 2021;147:111660. doi:
  16. /10.1016/j.lwt.2021.111660 DOI: 10.1016/j.lwt.2021.111660
  17. ] Fattahi R, Ghanbarzadeh B, Dehghannya J, Hosseini M, Falcone PM. The effect of Macro and Nano-emulsions of cinnamon essential oil on the properties of edible active films. Food Sci Nutr. 2020;8(12):6568-6579. doi: 10.1002/fsn3.1946 DOI: 10.1002/fsn3.1946
  18. ] da Silva BD, do Rosário DKA, Neto LT, Lelis CA, Conte- Junior CA. Antioxidant, antibacterial and antibiofilm activity of nanoemulsion-based natural compound delivery systems compared with non-nanoemulsified versions. Foods. 2023;12(9):1901. doi: 10.3390/ foods12091901
  19. ] Pontes CS, de Carvalho GG, Leite ARP, Chorilli M, Spolidorio DM. Improving drug delivery on Candida albicans using geraniol nanoemulsion. Pharmaceutics. 2023;15(10):2475. doi: 10.3390/pharmaceutics15102475 [18.] Atlas RM, Atlas RM. Handbook of Microbiological DOI: 10.3390/pharmaceutics15102475
  20. Media. CRC Press; 2004. doi: 10.1201/9781420039726 DOI: 10.1201/9781420039726
  21. ] Hidayati YA, Yusra MR, Puteri GCK, Marlina ET, Badruzzaman DZ, Harlia E. Macroscopic and microscopic isolation and identification of cellulolytic bacteria from mixtures of coal and beef cattle. In: Proceedings of the 3rd International Conference on Environmentally Sustainable Animal Industry (ICESAI 2022). Atlantis Press; 2023. p. 328-333. doi: 10.2991/978-94-6463-116- 6_41 DOI: 10.2991/978-94-6463-116-
  22. ] Purwasena IA, Astuti DI, Ardini Fauziyyah N, Putri DAS, Sugai Y. Inhibition of microbial influenced corrosion on carbon steel ST37 using biosurfactant produced by Bacillus sp. Mater Res Express. 2019;6(11):1057-1057. doi: 10.1088/2053-1591/ab4948 DOI: 10.1088/2053-1591/ab4948
  23. ] Sharma D, Saharan BS. Functional characterization of biomedical potential of biosurfactant produced by Lactobacillus helveticus. Biotechnol Rep (Amsterdam). 2016;11:27-35. doi: 10.1016/j.btre.2016.05.001 DOI: 10.1016/j.btre.2016.05.001
  24. ] Ni W, Shao X, Di X, Cui J, Wang R, Liu Y. In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(10):2531-2541. doi: 10.1093/jac/dku242 DOI: 10.1093/jac/dku242
  25. ] Nirmala J, Durai L, Gopakumar V, Nagarajan R. Preparation of Celery Essential Oil-Based Nanoemulsion by Ultrasonication and Evaluation of Its Potential Anticancer andAntibacterialActivity. Int J Nanomedicine. 2020;15:7651-7666. doi: 10.2147/IJN.S252640 DOI: 10.2147/ijn.s252640
  26. ] Kumar P, Kumar A. A review on biosurfactants: Fermentation, current developments and perspectives. World J Microbiol Biotechnol. 2020;36(1):1-12. doi: 10.1007/s11274-020-02841-8 DOI: 10.1007/s11274-020-02841-8
  27. ] Ceresa E. Microbial biosurfactants: Antimicrobial activity and potential biomedical applications. Front Bioeng. 2023;7(1):1-12. doi: 10.3389/fbioe.2020.00001 DOI: 10.3389/fbioe.2020.00001
  28. ] Goswami M, Deka S. Biosurfactant production by a rhizosphere bacteria Bacillus altitudinis MS16 and its promising emulsification and antifungal activity. J Microbiol Biotechnol. 2019;36(1):1-12. doi: 10.1007/ s11274-020-02841-8
  29. ] Das D, Mohapatra SS, Ray P. Optimization culture conditions and biosurfactant production from Bacillus altitudinis (BMSed II). J Pure Appl Microbiol. 2015;9(2):475-485.
  30. ] Atef A, Abo Elsoud MM, Elkhouly HI, Sidkey NM. Production, properties and application trends of iturin biosurfactant produced from Bacillus altitudinis AHMNAZ2. Egypt Hosp Med. 2023;93:7488-
  31. Available from: https://www.researchgate.net/
  32. publication/377013683
  33. ] Zhang J, Feng W, Xue Q. Biosurfactant production and oil degradation by Bacillus siamensis and Bacillus altitudinis strains. J Appl Microbiol. 2023;135(4):1111- 1121. doi: 10.1111/jam.15507 DOI: 10.1111/jam.15507
  34. ] Varadavenkatesan BT, Murty VR. Production of a lipopeptide biosurfactant by a novel Bacillus sp. and its applicability to enhanced oil recovery. ISRN Microbiol. 2013;2013:621519. doi: 10.1155/2013/621519 DOI: 10.1155/2013/621519
  35. ] Pattnaik S, Padhan DK, Jana GK. Evaluation of cinnamon oil, peppermint oil, cardamom oil and orange oil as antimicrobial agents. J Pharm Res. 2010;3(2):414-416.
  36. ] Shahina Z, El-Ganiny AM, Minion J, Whiteway M, Sultana T, Dahms TES. Cinnamomum zeylanicum bark essential oil induces cell wall remodelling and spindle defects in Candida albicans. Fungal Biol Biotechnol. 2018;5(1):3. doi: 10.1186/s40694-018-0046-5 DOI: 10.1186/s40694-018-0046-5
  37. ] Tran HNH, Graham L, Adukwu EC. In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris. Appl Microbiol Biotechnol. 2020;104(20):8911- 8924. doi: 10.1007/s00253-020-1089-z DOI: 10.1007/s00253-020-1089-z
  38. ] Chaudhari LKD, Jawale BA, Sharma S, Sharma H, Mounesh Kumar CD, Kulkarni PA. Antimicrobial activity of commercially available essential oils against Streptococcus mutans. J Contemp Dent Pract. 2012;13(1):71-74.
  39. ] Ganić T, Vuletić S, Nikolić B, Stevanović M, Kuzmanović M, Kekić D, Đurović S, Cvetković S, Mitić-Ćulafić D. Cinnamon essential oil and its emulsion as efficient antibiofilm agents to combat Acinetobacter baumannii. Front Microbiol. 2022;13:989667. doi: 10.3389/fmicb.2022.989667 DOI: 10.3389/fmicb.2022.989667
  40. ] Syafiq MO, Sapuan R, Zuhri M. Effect of cinnamon essential oil on morphological, flammability and thermal properties of nanocellulose fibre–reinforced starch biopolymer composites. Nanotechnol Rev. 2020;9(1):1147-1159. doi: 10.1515/ntrev-2020-0087 DOI: 10.1515/ntrev-2020-0087
  41. ] Liu H, Hu D, Wang D, et al. In vitro analysis of synergistic combination of polymyxin B with 12 other antibiotics against MDR Acinetobacter baumannii isolated from a Chinese tertiary hospital. J Antibiot. 2023;76:20-26. doi: 10.1038/s41429-022-00573-z DOI: 10.1038/s41429-022-00573-z
  42. ] Xu X, Xu L, Yuan G, Wang Y, Qu Y, Zhou M. Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance. Sci Rep. 2018;8:25714. doi: 10.1038/s41598-018-25714-z DOI: 10.1038/s41598-018-25714-z
  43. ] Cheesman MJ, Ilanko A, Blonk B, Cock IE. Developing new antimicrobial therapies: Are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution?. Pharmacol Rev. 2017;11(22):57-72. doi: 10.4103/phrev.phrev_21_17 DOI: 10.4103/phrev.phrev_21_17
  44. ] Gupta A, Eral B, Hatton T, Doyle P. Nanoemulsions: Formation, properties and applications. Soft Matter. 2016;12:10. doi: :1039/C5SM02958A.
  45. ] Hamouda T, Myc A, Donovan B, Shih AY, Reuter JD, Baker JR Jr. A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiol Res. 2001;156:1-7.
  46. ] Buranasuksombat U, Kwon Y, Turner M, Bhandari B. Influence of emulsion droplet size on antimicrobial properties. Food Sci Biotechnol. 2011;20:793-800. doi: 10.1007/s10068-011-0110-x DOI: 10.1007/s10068-011-0110-x
  47. ] Kumar M, Bishnoi RS, Shukla AK, Jain CP. Techniques for formulation of nanoemulsion drug delivery system: A review. Prev Nutr Food Sci. 2019;24(3):225-234. doi: 10.3746/pnf.2019.24.3.225 DOI: 10.3746/pnf.2019.24.3.225
  48. ] Algahtani M, Ahmad M, Ahmad J. Investigation of factors influencing formation of nanoemulsion by spontaneous emulsification: Impact on droplet size, polydispersity index, and stability. Bioengineering. 2022;9:384. doi: 10.3390/bioengineering9080384 DOI: 10.3390/bioengineering9080384
  49. ] Listyorini N, Wijayanti NPA, Astuti K. Optimasi pembuatan nanoemulsi virgin coconut oil. J Kimia. 2018;8. doi: 10.24843/JCHEM.2018.v12.i01.p02 DOI: 10.24843/jchem.2018.v12.i01.p02
  50. ] Weerapol Y, Limmatvapirat S, Nunthanid J, Sriamornsak P. Self-nanoemulsifying drug delivery system of nifedipine: Impact of hydrophilic–lipophilic balance and molecular structure of mixed surfactants. AAPS PharmSciTech. 2014;15:456-464. doi: 10.1208/s12249- 013-0056-6 DOI: 10.1208/s12249-
  51. ] Rizki T, Yasni S, Tjahja M, Yuliani S. Sintesis nanoemulsi dari ekstrak kulit manggis dengan metode energi tinggi. J Teknol Industri Pangan. 2023;34:109-118. doi: 10.6066/ jtip.2023.34.1.109
  52. ] Khan W, Ansari VA, Hussain Z, Siddique NF. Nanoemulsion: A droplet nanocarrier system for enhancing bioavailability of poorly water soluble drugs. Res J Pharm Technol. 2018;11(11):1. doi: 10.5958/0974- 360x.2018.00948.4 DOI: 10.5958/0974-
  53. ] Nirmal N, Chunhavacharatorn P, Khanashyam AC, Li L, Al-Asmari F. Cinnamon bark oil in water nanoemulsion formulation, characterization, and antimicrobial activities. LWT. 2023;179:114671. doi: 10.1016/j. lwt.2023.114671 DOI: 10.1016/j
  54. ] Lee VA, Kung YK, Amaechi B. Effect of antimicrobial nanoemulsion on oral biofilm. J Nanomed. 2009;9(2):1-
  55. Available from: https://doi.org/10.2147/IJN.S252640 [51.] Singh M, Rehman A, Hassan N, Anfey FA, Das A, Rahman M, Ansari MJ, Sharma N, Dudeja M, Aqil M, DOI: 10.2147/ijn.s252640
  56. Mirza MA, Iqbal Z. Exploration of a W/O nanoemulsion for antibiofilm activity against cariogenic Enterococcus faecalis. ACS Omega. 2023;8(3):2871-2879. doi: 10.1021/acsomega.2c03180 DOI: 10.1021/acsomega.2c03180
  57. ] Lin YT, Tsai WC, Lu HY, Fang SY, Chan HW, Huang CH. Enhancing therapeutic efficacy of cinnamon essential oil by nanoemulsification for intravaginal treatment of Candida vaginitis. Int J Nanomed. 2024;19:4941-4956. doi: 10.2147/IJN.S458593 DOI: 10.2147/ijn.s458593
  58. ] Juniatik M. Formulation of nanoemulsion mouthwash combination of essential oil and biosurfactant. J Nanomed. 2017;9(2):1-12. doi: 10.2147/IJN.S252640 DOI: 10.2147/ijn.s252640